Andreas Muehler - 12 May 2022 Form 4 Insider Report for IMMUNIC, INC. (IMUX)

Role
Chief Medical Officer
Signature
/s/ Andreas Muehler
Issuer symbol
IMUX
Transactions as of
12 May 2022
Net transactions value
+$17,850
Form type
4
Filing time
16 May 2022, 08:30:27 UTC
Previous filing
06 Jan 2022
Next filing
17 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMUX Common Stock Purchase $17,850 +3,500 +1.2% $5.10 297,986 12 May 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of 13,506 shares of common stock held directly by the Reporting Person and 284,480 shares of common stock held indirectly by Xanomed GmbH, an entity controlled by the Reporting Person.